Mydriacyl (Tropicamide)

Tropicamide, the active ingredient in Mydriacyl, is an anticholinergic (muscarinic antagonist) presented as a 0.5% w/v ophthalmic solution for ocular (topical) use. It produces reversible pupil dilation and cycloplegia, facilitating detailed eye examinations, refraction assessments, and intra‑ocular surgical procedures in patients of all ages.

GNH USA supplies Mydriacyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory support, and consistent product quality for ophthalmic care. Our global distribution network ensures timely delivery across Europe, Asia, Africa and the Americas.

Mydriacyl (tropicamide) acts on the muscarinic receptors of the eye to produce controlled dilation and cycloplegia. - Eye examination: induces mydriasis for detailed retinal evaluation. - Refraction: provides cycloplegia to allow accurate measurement of refractive error. - Intraocular surgery: facilitates pupil dilation and relaxation of the ciliary muscle during procedures.

Adverse reactions may occur following ocular administration of Mydriacyl.

Common Side Effects: - Transient stinging or burning sensation at the instillation site. - Mild blurred vision lasting several hours. - Temporary photophobia due to enlarged pupil. - Slight increase in intraocular pressure in susceptible individuals.

Serious or Rare Side Effects: - Acute angle‑closure glaucoma. - Severe allergic reaction such as eyelid edema, rash, or urticaria. - Systemic anticholinergic toxicity (rare) presenting with dry mouth, tachycardia, or confusion.

Before using Mydriacyl, consider the following safety measures. - Assess intraocular pressure: avoid in patients with narrow‑angle glaucoma. - Avoid concurrent use with other mydriatics: may cause excessive dilation. - Use with caution in children: increased sensitivity to anticholinergic effects. - Do not apply to infected ocular surface: risk of systemic absorption. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at room temperature: keep in original container, protect from light and moisture.

Mydriacyl may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Other anticholinergic agents: additive systemic anticholinergic effects. - Miotic agents (e.g., pilocarpine): antagonistic effect reducing efficacy.

Moderate Interactions (Monitor Closely): - Topical anesthetics: may increase ocular absorption of tropicamide. - Beta‑blocker eye drops: monitor intraocular pressure closely. - Systemic antihistamines: may enhance mydriasis and photophobia.